{
  "docId": "019de074-05b7-71fd-bc3c-27f1b7be8924",
  "docSlug": "c3cb552ef3a6b077a714c97117e1fe86",
  "documentTitle": "Mink Therapeutics | Investor Day Presentation Deck | 92 slides",
  "authorId": "mink-therapeutics",
  "authorName": "MiNK Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 27,
  "pageCount": 92,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The slide presents clinical efficacy metrics (ORR, SD, mOS) and safety profile for iNKT cell therapy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-05b7-71fd-bc3c-27f1b7be8924/27",
  "deckHref": "/decks/019de074-05b7-71fd-bc3c-27f1b7be8924",
  "deckJsonHref": "/decks/019de074-05b7-71fd-bc3c-27f1b7be8924.json",
  "deckAnchorHref": "/decks/019de074-05b7-71fd-bc3c-27f1b7be8924#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.56,
        "x": 0.22,
        "y": 0.69
      },
      "kind": "callout",
      "text": "Favorable safety with four Grade 3 AEs (n=43 patients in 5 trials); no serious cytokine release or neurotoxicity; up to 1 billion cells per patient, comparable to approved cell therapies",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e09cc89-267b-444a-b16e-4babd3c2f101",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.25,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Adapted from: Yamasaki et al, Clin Immunol 2011; Exley et al, Clin Cancer Res, 2017; Gao et al, Oncologist 2021",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78439c06-4d68-4db0-982b-44a94149436b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.56,
        "x": 0.22,
        "y": 0.22
      },
      "kind": "table",
      "text": "Autologous iNKTs in Solid Tumors | Clinical Outcomes; Head and Neck Cancer (SCCHN) | ORR: 50%; Non-Small Cell Lung Cancer (NSCLC) | SD: 67% (4/6); Advanced Hepatocellular Carcinoma (HCC) | mOS: 13 months Historical: <6 months",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59822b6f-fd84-401f-9b2d-aad5615db8aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Allo-INKTs (agent-797) Alone or In Combination with PD-1 Inhibitors Builds on Observations of Activity of iNKTs in Solid Tumors",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9ceb6cf2-91fa-4768-8ffe-0213c510b339",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "16534c92-0d57-43d8-8aa4-aaec83625ca6",
      "evidence": "table/data: Autologous iNKTs in Solid Tumors | Clinical Outcomes; Head and Neck Cancer (SCCHN) | ORR: 50%; Non-Small Cell Lung Cancer (NSCLC) | SD: 67% (4/6); Advanced Hepatocellular Carcinoma (HCC) | mOS: 13 months Hist",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 35,
      "from": 23,
      "beatId": "3ca2588f-ae86-4809-9434-ea06292b2cdd",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "The presentation provides preclinical and clinical data supporting iNKT cells' potential",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 35,
      "from": 23,
      "name": "Before After",
      "slug": "21-before-after",
      "bestFor": "Product demos, process improvements, ROI justification",
      "matchId": "d3a14978-bf9f-4a75-b0e8-87c8ef56ddbf",
      "evidence": "The presentation uses before-after comparisons to show iNKT cells' potential",
      "position": 1,
      "objective": "Illustrating the benefits of iNKT cells",
      "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
      "confidence": 0.7,
      "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}